Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Alvotech Logo
Alvotech Growth Score
79
CB Rank
282
Heat Score
80
Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.
Founded
obfuscation
PublicPost-IPO Equity Reykjavík, Gullbringusysla, Iceland1001-5000 www.alvotech.com
Biotechnology
Health Care
Life Science
Pharmaceutical
Overview

Alvotech
Total Funding
obfuscation
Growth Score
79
Heat Score
80

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score79
-18 pts
in past quarter
Heat Score 80
9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+5 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Alvotech

CB Rank
282
Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.
Founded
obfuscation
PublicPost-IPO Equity Reykjavík, Gullbringusysla, Iceland1001-5000 www.alvotech.com
Biotechnology
Health Care
Life Science
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name ALVOTECH ehf.
Also Known As Alvotech Biosimilars
Operating Status Active
Stock Symbol  NASDAQ:ALVO
Company Type For Profit
Founders  Róbert Wessman
About the Company

Alvotech is a fully integrated specialty biopharmaceutical company focused exclusively on the development and manufacture of high-quality biosimilar medicines. The company's goal is to improve patients' health and quality of life around the world by increasing access to effective therapies for various ailments.

Alvotech was established

on January 1, 2013, by Róbert Wessman in Reykjavík, Gullbringusysla.

Phone Number +354 422 4500
Contact Email contact-us@alvotech.com
Hub Tags  Exited Unicorn
Predictions & Insights

Growth Insight

See this Growth Insight
Alvotech is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

Biosimilar Monoclonal Antibodies and Fusion Proteins
Development and manufacturing of biosimilar monoclonal antibodies and fusion proteins for treating immune and inflammatory conditions.
Alvo AI-powered marketing automation platform
A platform that converts any web link into an AI-generated, multi-channel advertising campaign in minutes.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 13
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Alvotech Logo
Post-IPO Equity - Alvotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Alvotech Logo
Post-IPO Equity - Alvotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Alvotech Logo
Post-IPO Equity - Alvotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Alvotech Logo
Post-IPO Equity - Alvotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Alvotech Logo
Post-IPO Equity - Alvotech
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 13
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Alvotech Logo
Post-IPO Equity - Alvotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Alvotech Logo
Post-IPO Equity - Alvotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Alvotech Logo
Post-IPO Equity - Alvotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Alvotech Logo
Post-IPO Equity - Alvotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Alvotech Logo
Post-IPO Equity - Alvotech
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
GoldenTree Asset Management Logo
GoldenTree Asset Management
Yes
Post-IPO Debt - Alvotech Logo
Post-IPO Debt - Alvotech
—
GoldenTree Asset Management Logo
GoldenTree Asset Management
Yes
Post-IPO Debt - Alvotech Logo
Post-IPO Debt - Alvotech
—
GoldenTree Asset Management Logo
GoldenTree Asset Management
Yes
Post-IPO Debt - Alvotech Logo
Post-IPO Debt - Alvotech
—
GoldenTree Asset Management Logo
GoldenTree Asset Management
Yes
Post-IPO Debt - Alvotech Logo
Post-IPO Debt - Alvotech
—
GoldenTree Asset Management Logo
GoldenTree Asset Management
Yes
Post-IPO Debt - Alvotech Logo
Post-IPO Debt - Alvotech
—

Investments

Number of Acquisitions 3

Investment Breakdown

Number of Acquisitions 3
Market Intelligence
People
View Profiles & Contacts
Headcount 1001-5000 Employee Profiles 16 Board Members and Advisors 2 Contacts 133

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 22, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 22, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

5,975
-73.34%
 in past month

Interest Signals

TopicSurge Score
Reddit Logo
Reddit
97
Acer Logo
Acer
96
Economic Growth Logo
Economic Growth
87

Actively Used Products

18Alvotech uses 18 technology products and services including HTML5, Microsoft Outlook, and  Office 365, according to G2 Stack.

Active Website Tech Count

30Alvotech is actively using 30 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.
Sub-Organizations
Frequently Asked Questions

Where is Alvotech's headquarters? Alvotech is located in Reykjavík, Gullbringusysla, Iceland.Who invested in Alvotech? Alvotech has 7 investors including GoldenTree Asset Management and  Alvogen.When was the last funding round for Alvotech? Alvotech closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Alvotech's competitors? Alternatives and possible competitors to Alvotech may include NewLimit, Golden Gate Ventures, and  Sanofi.How much funding has Alvotech raised to date? Alvotech has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|